Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia

Nephron

Volumn 88, Issue 4, 2001, Pages 329-333

  Grekas, Dimitrios ^a   Kassimatis, E ^a   Makedou, A ^a   Bacharaki, D ^a   Bamichas, G ^a   Tourkantonis, A ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Dyslipidemia; Fish oil; Pravastatin; Renal transplantation

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; AZATHIOPRINE; CHOLESTEROL; CREATINE KINASE; CREATININE; CYCLOSPORIN A; FIBRINOGEN; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; PRAVASTATIN; PROLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW FAT DIET; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL, LDL; COMBINED MODALITY THERAPY; DIETARY FATS; FEMALE; FISH OILS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MIDDLE AGED; PRAVASTATIN; TIME FACTORS;

EID: 0034934329     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046016     Document Type: Article

References (21)

1. Clinical correlation between renal allograft failure and hyperlipidemia
2. Hyperlipidemia after renal transplantation-facts and potential implications
3. Causes, consequences and treatment of hyperlipidemia in patients with renal disease
4. Clinical utility of antilipidemic therapies in chronic renal allograft failure
5. Independent effects of cyclosporine and prednisone on post-transplant hypercholesterolemia
6. Lipid abnormalities in uremia, dialysis and transplantation
7. Cyclosporine, low-density lipoprotein, and cholesterol
8. Impaired glucose tolerance in cyclosporine treated renal graft recipients
9. Lipid abnormalities in end stage renal disease
10. Dietary fish oils slow progression of chronic renal graft failure
11. Trial results. II The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
12. Changes in the causes of death after renal transplantation, 1966 to 1987
13. Posttransplant hyperlipidemia: The treatment dilemma
14. HMG-CoA reductase inhibitor-induced myopathy in the rat. Cyclosporine A interaction and mechanism studies
15. The effects of pravastatin on hyperlipidemia in renal transplant recipients
16. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia
17. Lipoprotein lipid abnormalities in healthy renal transplant recipients: Persistence of low HDL2 cholesterol
18. HMG-CoA reductase inhibitors lower LDL-cholesterol without reducing Lp(a) levels
19. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: Lipid lowering and immuno-suppression
20. The effect of pravastatin on acute rejection after kidney transplantation - A pilot study